Medicare Enrolled
Dr. Sanjay Kaul, M.D.
Optician · Los Angeles, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kaul from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kaul?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kaul
Dr. Sanjay Kaul is an optician specialist in Los Angeles, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kaul performed 8,675 Medicare services across 4,165 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kaul received a total of $1,391,425 from 58 pharmaceutical and/or device companies across 410 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kaul is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 10% volume in CA
$1,391,425 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,675
Medicare services
Top 10% in CA for optician
4,165
Unique beneficiaries
$25
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~457 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,140 | $18 | $34 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
622 | $51 | $130 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
499 | $11 | $162 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
471 | $8 | $44 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
466 | $8 | $68 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
459 | $10 | $108 |
| High-sensitivity C-reactive protein test A blood test that measures high-sensitivity C-reactive protein to detect infection or inflammation. |
446 | $13 | $98 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
444 | $3 | $44 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
422 | $108 | $322 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
414 | $4 | $47 |
| Natriuretic peptide level test A blood test that measures the level of natriuretic peptide, a protein produced by the heart and blood vessels. |
407 | $38 | $280 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
315 | $7 | $84 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
301 | $16 | $143 |
| Erythrocyte sedimentation rate (ESR) test A blood test that measures how quickly red blood cells settle in a test tube to detect inflammation in the body. This specific method is performed manually rather than using an automated machine. |
298 | $4 | $54 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
287 | $13 | $88 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
272 | $9 | $145 |
| Free thyroxine (T4) test A blood test that measures the level of free thyroxine, a thyroid hormone, in the bloodstream. |
246 | $9 | $112 |
| Total T3 thyroid hormone test A blood test that measures the total amount of triiodothyronine (T3) hormone in your body. T3 is a thyroid hormone that helps regulate metabolism and energy levels. |
246 | $14 | $142 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
166 | $29 | $70 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
102 | $159 | $940 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
93 | $152 | $359 |
| PSA test (prostate cancer screening) | 76 | $18 | $146 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
46 | $84 | $818 |
| Follow-up ultrasound of heart blood flow, valves and chambers An ultrasound exam that follows up on the heart's blood flow, valves, and chambers. It uses sound waves to create images of the heart's structure and function. |
46 | $23 | $368 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
46 | $22 | $561 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
33 | $70 | $189 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
31 | $17 | $93 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
30 | $147 | $997 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
29 | $30 | $186 |
| Troponin blood test A blood test that measures the amount of troponin protein in your body. Troponin is released into the blood when heart muscle is damaged. |
27 | $12 | $66 |
| New patient office visit, complex (60-74 min) | 27 | $178 | $613 |
| Cardiac enzyme level (CK-MB) test A blood test that measures the total level of creatine kinase, specifically the cardiac enzyme fraction, to help evaluate heart muscle damage. |
24 | $6 | $41 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
23 | $73 | $145 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
21 | $72 | $76 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
21 | $34 | $55 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
19 | $13 | $137 |
| Lipase level test A blood test that measures the amount of lipase, a fat-digesting enzyme, in your body. |
17 | $7 | $37 |
| Amylase enzyme level test A blood test that measures the amount of amylase, an enzyme produced by the pancreas and salivary glands, to help evaluate pancreatic health. |
16 | $6 | $97 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
16 | $15 | $165 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
11 | $14 | $148 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.7% high complexity
14.8% medium
83.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$1,391,425
Total received (2018-2024)
Avg $198,775/year across 7 years
Top 0% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
410
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,151,454 (82.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$218,472 (15.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$21,500 (1.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$81,559
2023
$199,654
2022
$110,163
2021
$142,884
2020
$247,832
2019
$256,602
2018
$352,732
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$17,468
Janssen Research & Development, LLC
$17,000
Novartis Pharmaceuticals Corporation
$16,458
AstraZeneca Pharmaceuticals LP
$15,000
Amgen Inc.
$13,203
Bayer Healthcare Pharmaceuticals Inc.
$2,262
Lexicon Pharmaceuticals, Inc.
$37
ABBVIE INC.
$33
Esperion Therapeutics, Inc.
$29
Lilly USA, LLC
$27
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$24
Philips North America LLC
$18
Top 3 companies account for 62.4% of 2024 payments
All-time payments by company (2018-2024) ›
Boehringer Ingelheim International GmbH
$349,191
Novo Nordisk Inc
$63,519
GlaxoSmithKline, LLC.
$62,350
Boehringer Ingelheim (Phil.) Inc.
$59,125
Boehringer Ingelheim India Pvt. Ltd.
$53,394
Bayer HealthCare Pharmaceuticals Inc.
$50,637
Boehringer Ingelheim Pharmaceuticals, Inc.
$50,369
Amgen Inc.
$43,019
Boehringer Ingelheim MENA (Scientific Office) FZ-LLC
$36,365
Janssen Research & Development, LLC
$33,663
SANOFI-AVENTIS U.S. LLC
$30,079
Boehringer Ingelheim Malaysia Sdn. Bhd.
$29,996
Novartis Pharmaceuticals Corporation
$27,546
AbbVie Inc.
$26,439
AstraZeneca Pharmaceuticals LP
$26,420
Regeneron Pharmaceuticals, Inc.
$26,036
Eli Lilly and Company
$25,620
Sarepta Therapeutics, Inc.
$25,000
Takeda Pharmaceuticals U.S.A., Inc.
$24,197
Vertex Pharmaceuticals Incorporated
$24,000
SANOFI US SERVICES INC.
$20,592
Boehringer Ingelheim Singapore Pte. Ltd.
$16,946
Intercept Pharmaceuticals, Inc.
$16,401
Bayer Healthcare Pharmaceuticals Inc.
$16,131
Eisai Inc.
$16,000
Alnylam Pharmaceuticals Inc.
$16,000
Cardinal Health 200, LLC
$14,871
Medtronic, Inc.
$14,563
Ardelyx, Inc.
$14,450
Pharmacyclics LLC, An AbbVie Company
$14,400
Acrotech Biopharma Inc.
$14,400
Endologix LLC
$14,400
Shire North American Group Inc
$14,365
AbbVie, Inc.
$14,273
Gilead Sciences, Inc.
$13,600
Edwards Lifesciences Corporation
$13,020
Merck Sharp & Dohme Corporation
$12,659
Neovasc Medical Inc
$12,000
Bard Peripheral Vascular, Inc.
$12,000
Medtronic Vascular, Inc.
$11,231
Ipsen Bioscience Inc
$10,500
AKEBIA THERAPEUTICS INC
$9,800
PT Boehringer Ingelheim Indonesia
$5,158
Boehringer Ingelheim Saudi Arabia Trading
$3,480
Heron Therapeutics, Inc.
$1,300
AstraZeneca UK Limited
$1,260
Abbott Laboratories
$345
Lilly USA, LLC
$52
Lexicon Pharmaceuticals, Inc.
$37
PFIZER INC.
$35
ABBVIE INC.
$33
Esperion Therapeutics, Inc.
$29
Janssen Pharmaceuticals, Inc
$27
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$24
HeartFlow, Inc.
$24
Daiichi Sankyo Inc.
$19
Philips North America LLC
$18
E.R. Squibb & Sons, L.L.C.
$15
Top 3 companies account for 34.1% of all-time payments
Associated products mentioned in payments ›
(AK6) Vest Therapy · AFX2 Bifurcated Endograft System · ANORO · Adempas · Auryxia · BELEODAQ · BEVESPI AEROSPHERE · CARVYKTI · COBALT DR MRI SURESCAN · CareLink · Corlanor · DUPIXENT DUPILUMAB INJECTION · ELIQUIS · ENTRESTO · EYLEA HD · Edwards SAPIEN 3 Transcatheter Heart Valve · FARXIGA · FFRct · GLYXAMBI · HTX-011 · IMBRUVICA · INCRAFT AAA Stent Graft System · INJECTAFER · INVOKANA · JARDIANCE · Kerendia · LEQVIO · LINQ II · Leqembi · MICRA · MOUNJARO · Micra · NEXLETOL · NO PRODUCT DISCUSSED · Non-Covered · Norditropin · PASCAL · PRALUENT · RINVOQ · Repatha · SOTAGLIFLOZIN · SYNTHROID · TAGRISSO · TRELEGY ELLIPTA · Uloric · VYNDAQEL · XARELTO · XIFAXAN
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (83%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 0% for optician in CA.
Geographic Context
Opticians within 10 mi
1,540
Per 100K population
15.6
County median income
$87,760
Nearest hospital
CEDARS-SINAI MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kaul is a mixed practice specialist, with above-average Medicare volume (top 10% in CA), with consulting-driven industry engagement in the top 0% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kaul experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Kaul performed 1,140 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kaul receive payments from pharmaceutical companies?
Yes. Dr. Kaul received a total of $1,391,425 from 58 companies across 410 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kaul's costs compare to other opticians in Los Angeles?
Dr. Kaul's average Medicare payment per service is $25. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kaul) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Los Angeles
Browse opticians in Los Angeles ranked by procedure volume and transparency data.
Highest volume
Top Opticians in CA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in CA
Which CA opticians receive the most from drug and device companies.
By company
Boehringer Ingelheim International GmbH Payments to Doctors
See all physicians who received payments from Boehringer Ingelheim International GmbH.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology